Abstract | BACKGROUND: METHODS: A literature search was undertaken in PubMed and Medline, for literature published between January 1, 2007 and August 31, 2013. RESULTS AND CONCLUSIONS: A total of eight research questions were developed and, using the National Health and Medical Research Council's evidence assessment framework, conclusions were made in relation to dietary intake of fish and omega-3 LCPUFA for cardiovascular health. In the evidence published since 2007, this summary of evidence concludes that dietary intake of fish was found to be mostly consistent with respect to protection from heart disease and stroke. Higher fish intake was associated with lower incident rates of heart failure in addition to lower sudden cardiac death, stroke and myocardial infarction. In relation to omega-3 LCPUFA supplementation, neither a beneficial nor adverse effect was demonstrated in primary or secondary prevention of coronary heart disease (CHD). Although the evidence continues to be positive for the role of omega-3 LCPUFA in the treatment of hypertriglyceridaemia and a modest positive benefit in heart failure. No further evidence was found to support the consumption of 2g alpha-linolenic acid (ALA)/day over the current Australian guidelines for 1 g/day.
|
Authors | Paul Nestel, Peter Clifton, David Colquhoun, Manny Noakes, Trevor A Mori, David Sullivan, Beth Thomas |
Journal | Heart, lung & circulation
(Heart Lung Circ)
Vol. 24
Issue 8
Pg. 769-79
(Aug 2015)
ISSN: 1444-2892 [Electronic] Australia |
PMID | 25936871
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. |
Chemical References |
|
Topics |
- Animals
- Cardiovascular Diseases
(prevention & control)
- Dietary Supplements
- Fatty Acids, Omega-3
(therapeutic use)
- Humans
|